LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.
HKSE: 2291.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Industrials
- Industry
- Specialty Business Services
- CEO
- Juan Chen
- Employees
- 314
- Headquarters
- Shanghai, China
- IPO year
- 2022
- Market cap
- HK$3.9B
- Website
- https://www.scientechmed.com
Loading 2291…
Loading profile data…Frequently asked questions about 2291
What does LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK) do?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, an...
Where does 2291.HK trade?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK) trades on the Hong Kong Stock Exchange.
What sector is 2291.HK in?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK) operates in the Industrials sector, specifically in the Specialty Business Services industry.
Who is the CEO of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.?
Juan Chen is the chief executive officer of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK).
Where is LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. headquartered?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is headquartered in China.
Does 2291.HK pay a dividend?
Yes — LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK) paid a trailing twelve-month dividend of HKD 0.67 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 2291.HK go public?
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK) completed its initial public offering in 2022.